FT : Diageo warns of hit to profits from slowdown in Latin America and Caribbean

Diageo warns of hit to profits from slowdown in Latin America and Caribbean
Shares tumble 15% after drinks group says growth will slow in first half on back of worsening sales slump

Drinks group Diageo has warned that growth in operating profits will slow in the six months to the end of December on the back of a deepening sales slump in Scotch whisky in Latin America and the Caribbean, sending its shares down 15 per cent.

In an unscheduled trading update on Friday, the maker of Johnnie Walker, Tanqueray and Guinness said it expected sales in Latin America and the Caribbean to fall 20 per cent in the group’s first half, squeezing profits.

As a result, Diageo predicts “organic operating profit growth for the first half of fiscal 24 to decline compared to the first half of fiscal 23”. The share price drop left Diageo the biggest faller on the blue-chip FTSE 100 index on Friday.

“Macroeconomic pressures have worsened and that caused lower consumption and really more consumer downtrading than what the team was expecting,” said chief executive Debra Crew, addressing the slump in Latin America, where Diageo’s business is primarily in Scotch whisky.

Diageo’s largest markets in the region are Brazil and Mexico, followed by Central American and Caribbean countries. In total the region accounts for roughly 11 per cent of the value of the group’s sales, the majority of which are driven by its Scotch brands Johnnie Walker Black Label, Johnnie Walker Red Label and Old Parr.

Both the Brazilian and Mexican economies are showing better than expected growth but anecdotal evidence suggests that whisky is going out of fashion for those who can afford it, with younger drinkers favouring top-end vodka or newer offerings such as craft gin. 

Eric Franco, a 35 year old museum worker in Mexico City, said whisky was appearing less frequently at parties. “I feel like it’s for slightly older people,” he said, saying he and his friends preferred beer, tequila and mezcal.

On Rio de Janeiro’s Copacabana beach, bartender Luan da Silva Cruz said Jack Daniels — owned by US group Brown-Forman — and Johnnie Walker Black Label tend to sell well. But he added that there is little demand for other brands and “among cocktails, the most popular by far is [national drink] caipirinha.”

At its last trading update in August, Diageo reported higher than expected inventory levels in Latin America and sales growth of 20 per cent in the first six months of 2023.

Crew said that because of the dampened economic environment, it had taken longer than expected to clear excess stock that was ordered when consumer demand was higher, adding that some wholesalers and retailers “may have purchased ahead of anticipated consumption” before interest rates started rising.

“With the volatility that we saw through the Covid supercycle, it’s been hard to see through what part of this was true consumption growth versus inventory increases,” she said.

Drinks groups prospered during the pandemic as consumers bought higher-end alcohol to make their own drinks at home during lockdowns. The party continued when countries reopened, but slowing sales at major drinks groups, particularly in North America, indicate that the boom is over.

Rivals including Pernod Ricard, Campari and LVMH’s wine and spirits division have all recently reported declining sales in the past quarter as consumers pushed back against price rises by trading down to cheaper brands or drinking less. Rémy Cointreau and Pernod Ricard’s shares each fell more than 4 per cent on Friday.

The gloomier outlook comes less than two months after Diageo told investors that operating profit growth would accelerate in the first half of its current financial year.

Speaking to journalists following the update on Friday, Crew, who started in the role in June, said the group expected an improvement in sales and profit growth in the second half of next year.

However RBC Capital Markets analysts James Edward Jones and Emma Letheren said: “If this is a temporary . . . then why did Diageo feel the need to up multiyear investment behind its global business? Our concern is that Diageo is facing a widespread retrenchment in premium spirits consumption caused by macroeconomic pressures around the world with an unknown end date.”

>>> ENI - Several investment banks have approached Italy's Treasury

ENI

MILAN, Nov 10 (Reuters) - Several investment banks have approached Italy's Treasury with offers to help it sell part of its stake in Eni ENI.MI, saying the group's current share buyback will allow Rome to reduce its holding without losing full control, sources said on Friday.

Italy aims to raise some 20 billion euros ($21.34 billion) from asset disposals through 2026 to slightly reduce the euro zone's second-largest debt pile as a proportion of gross domestic product.

Bankers have told the Treasury in recent weeks it should take advantage of Eni's stated plan to buy back and cancel 275 million of its shares to reduce its stake, three sources familiar with the matter said.
The option however is not top of the list for the Treasury, one of the sources added.

Italy currently owns around 32.4% stake in the energy group, chiefly through the 27.7% it holds indirectly via state lender Cassa Depositi e Prestiti (CDP) as the Treasury has a small direct 4.7% stake.

>>> US Research Calls

Research Calls II
  • Upgrades:
    • BJ's Wholesale (BJ) upgraded to Buy from Hold at Gordon Haskett
    • Bragg Gaming Group (BRAG) upgraded to Mkt Outperform from Mkt Perform at JMP Securities; tgt $8
    • Celldex Therapeutics (CLDX) upgraded to Equal Weight from Underweight at Wells Fargo; tgt $27
    • Dentsply Sirona (XRAY) upgraded to Outperform from Mkt Perform at William Blair
    • Diebold Nixdorf (DBD) upgraded to Buy from Neutral at DA Davidson; tgt raised to $29
    • Henry Schein (HSIC) upgraded to Buy from Hold at Stifel; tgt $70
    • Rogers Comms (RCI) upgraded to Buy from Hold at Desjardins
    • Southwestern Energy (SWN) upgraded to Outperform from Underperform at Wolfe Research; tgt $8
    • Teck Resources (TECK) upgraded to Outperform from Peer Perform at Wolfe Research
    • Toast (TOST) upgraded to Outperform from Neutral at Robert W. Baird; tgt $18
    • Vera Therapeutics (VERA) upgraded to Buy from Hold at Jefferies; tgt raised to $26
  • Downgrades:
    • 2U (TWOU) downgraded to Neutral from Overweight at Cantor Fitzgerald; tgt lowered to $1.50
    • American Airlines (AAL) downgraded to Neutral from Outperform at Exane BNP Paribas; tgt $12
    • Babcock & Wilcox Enterprises (BW) downgraded to Hold from Buy at Craig Hallum; tgt lowered to $2
    • CareMax (CMAX) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $2
    • Commscope (COMM) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $1.75
    • FREYR Battery (FREY) downgraded to Neutral from Buy at BTIG Research
    • Green Dot (GDOT) downgraded to Hold from Buy at Craig Hallum; tgt $14
    • Hawaiian Electric (HE) downgraded to Underweight from Equal Weight at Wells Fargo; tgt raised to $8.50
    • IBEX Ltd. (IBEX) downgraded to Neutral from Overweight at Piper Sandler; tgt $17
    • Illumina (ILMN) downgraded to Hold from Buy at Canaccord Genuity; tgt lowered to $120
    • JetBlue Airways (JBLU) downgraded to Underperform from Neutral at Exane BNP Paribas; tgt $3
    • Medical Properties Trust (MPW) downgraded to Hold from Buy at Stifel; tgt lowered to $4.50
    • Model N (MODN) downgraded to Neutral from Buy at BTIG Research
    • Occidental Petro (OXY) downgraded to Peer Perform from Outperform at Wolfe Research
    • Plug Power (PLUG) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $6
    • Plug Power (PLUG) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $5
    • Southwest Air (LUV) downgraded to Underperform from Neutral at Exane BNP Paribas; tgt $20
    • Unity Software (U) downgraded to Neutral from Outperform at Macquarie; tgt $20
    • Upland Software (UPLD) downgraded to Sell from Neutral at ROTH MKM; tgt $3.50
    • Vuzix (VUZI) downgraded to Neutral from Buy at BTIG Research
    • Wolverine (WWW) downgraded to Sell from Hold at Williams Trading; tgt lowered to $7
  • Others:
    • Bath & Body Works (BBWI) placed on Positive Catalyst Watch at Citigroup; tgt lowered to $34
    • Korro Bio (KRRO) initiated with an Overweight at Piper Sandler; tgt $180
    • NeuroPace (NPCE) initiated with an Overweight at Cantor Fitzgerald; tgt $11
    • Portillo's (PTLO) initiated with an Overweight at Stephens; tgt $20
    • Weatherford (WFRD) initiated with a Buy at BofA Securities; tgt $120

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • GRPN -34.4% (also Co-Founder Eric Lefkofsky to resign; to raise $100 mln to strengthen liquidity), PLUG -33.2%, TWOU -28.2%, TTD -24%, TMCI -19.4%, VUZI -16.7%, WEST -15.6%, BW -15.2% (also announces business realignment plan; considering strategic alternatives related to non-strategic assets), U -14.9% (also files for $1.0 bln 2.0% Convertible Senior Notes), MODN -12.3%, GDOT -11.4%, ILMN -11.2%, EVBG -7.1%, ADPT -5.6%, NWSA -5.6%, VYX -5%, PAR -4.9%, ONTO -4.8%, WYNN -4.7%, HE -4.6% (also to delay its 10-Q citing potential lawsuits), CLNE -4.5%, FLO -3.4%, BBDC -3.1%, CPRI -3%, CLFD -2.4% (also increases share repurchase program), AQN -1.6%, RBA -1.4%, LAW -1.2%
Other news:
  • TKO -6.8% (prices secondary offering of 8.4 mln shares of common stock at $79.80 per share) BRNS -5.8% (ABUS and BRNS announce a late breaking poster presentation)
  • NBIX -5.5% (Phase 2 study of NBI-1065846 in patients with anhedonia failed to meet primary endpoint)
  • IRDM -4.6% (QCOM elects to terminate agreements)
  • OABI -3.7% (Highlights OmnidAb Launch and its Expanding Drug Discovery Platform at co's Research & Technology Virtual Event)
  • LMND -3.6% (files mixed shelf securities offering; also files for offering by selling shareholder)
  • PIII -3.6% (files $250 mln mixed shelf securities offering)
  • GOL -3% (reports October metrics)
  • SKYW -2.1% (stock offering by selling shareholders)
  • AZUL -1.8% (reports October traffic increased 13.7% yr/yr)
  • XENE -1.3% (NBIX partner Phase 2 study of NBI-1065846 in patients with anhedonia failed to meet primary endpoint)
  • CPK -1% (prices offering of 3859649 shares of its common stock at an offering price of $85.50 per share)

Analyst comments:
  • COMM -4.5% (downgraded to Neutral from Buy at BofA Securities)
  • WWW -2.8% ( downgraded to Sell from Hold at Williams Trading)
  • MPW -2.2% (downgraded to Hold from Buy at Stifel)
  • LUV -1.2% (downgraded to Underperform from Neutral at Exane BNP Paribas)
  • AAL -0.5% (downgraded to Neutral from Outperform at Exane BNP Paribas)
  • JBLU -0.5% (downgraded to Underperform from Neutral at Exane BNP Paribas)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • DOCS +17.1% (also authorizes new $70 mln share repurchase program), BLNK +13.8%, RPAY +11.7%, INDI +9.3%, SYNA +8.7%, NVTS +7.6%, VZIO +7.2%, ALRM +7.1%, ORGN +6.5%, ARLO +6.1%, AVPT +3.9%, RXST +2.9%, VRRM +2.5% (also authorizes new $100 mln share repurchase program), TSM +2.4%, SOUN +2.3%, LGF.A +2.2%, HOLX +2.2%, ONL +1.6%, EC +1.3%, LNW +1.1%
Other news:
  • FIGS +10.8% (Ron Barron on CNBC says he is long FIGS)
  • OUST +10.7% (announces major software achievements to serve lidar-powered smart infrastructure)
  • IRWD +7% (files mixed shelf securities offering)
  • TARS +4.9% (files $300 mln mixed shelf securities offering)
  • VOR +4.3% (presents data on Trem-cel)
  • EGRX +4.1% (to delay 10-Q filing)
  • EVC +3.7% (CEO disclosed the purchase of 100000 shares at $3.85 (transaction date 11/8))
  • AIZ +3% (authorizes additional $600 mln in share repurchases; increases dividend)
  • HTGC +1.8% (receives SBA "green light" letter to submit its fourth SBIC license application)
  • VCTR +1.3% (reports Oct AUM)
  • PCRX +1.1% (FDA approval of expanded EXPAREL label to include two additional nerve block indications)
  • APAM +1% (reports Oct AUM)
Analyst comments:
  • VERA +8.1% (upgraded to Buy from Hold at Jefferies)
  • XRAY +2.8% (upgraded to Outperform from Mkt Perform at William Blair)
  • BJ +2.2% (upgraded to Buy from Hold at Gordon Haskett)
  • HSIC +1.8% (upgraded to Buy from Hold at Stifel)
  • TOST +1.3% (upgraded to Outperform from Neutral at Robert Baird)

>>> Stoxx 600 Pre-Market Indications

  • Novo (NOV TH) +0.3%
    • *NOVO TO INVEST MORE THAN DKK42B IN DANISH MANUFACTURING PLANT
  • Puma (PUM TH) -1.4%
  • Norsk Hydro (NOH1 TH) -1.4%
  • Vonovia (VNA TH) -1.4%
  • Rolls-Royce (RRU TH) -1.6%
  • Thyssenkrupp (TKA TH) -1.7%
    • THK 3Q Operating Income Misses Estimates
  • Diageo (GUI TH) -1.9%
    • Diageo PLC DGE Diageo issues trading update
  • Delivery Hero (DHER TH) -2%
  • Ryanair (RY4C TH) -2.1%
  • Adyen (1N8 TH) -2.2%
  • Nel (D7G TH) -7.6%

>>> TradeGate Pre-Market Indications

DAX:
  • Siemens Energy (ENR TH) +0.3%
    • Siemens Energy Talks on Loan Guarantees Are Still Ongoing
  • SAP (SAP TH) -1%
  • Allianz (ALV TH) -1.1%
    • Allianz Beat Estimates as Pimco Sees Third Quarter of Inflows
  • Vonovia (VNA TH) -1.4%
MDAX:
  • Evonik (EVK TH) +0.9%
  • United Internet (UTDI TH) -1.2%
    • United Internet 9M Sales EU4.59B Vs. EU4.38B Y/y
  • Jungheinrich (JUN3 TH) -1.7%
    • Jungheinrich 3Q Ebit Meets Estimates
  • Thyssenkrupp (TKA TH) -1.7%
    • THK 3Q Operating Income Misses Estimates
SDAX:
  • Ionos (IOS TH) +2.8%
    • Ionos Sees FY Adjusted Ebitda Margin 27.5%, Saw at Least 27%
  • 1&1 (DRI TH) -1.3%
    • 1&1 Maintains FY Service Revenue Forecast
  • SFC Energy (F3C TH) -1.4%
  • Heidelberger Druck (HDD TH) -1.7%
  • MorphoSys (MOR TH) -3.1%